 | • レポートコード：GIR-23F3932 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Soliris Drug Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界のソリリス医薬品の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 ソリリス医薬品市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・血漿交換、血漿注入 アプリケーション別セグメントは次のように区分されます。 ・PNH、aHUS、その他 世界のソリリス医薬品市場の主要なマーケットプレーヤーは以下のとおりです。 ・Alexion 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - ソリリス医薬品の概要 - タイプ別分析（2017年vs2021年vs2028年）：血漿交換、血漿注入 - アプリケーション別分析（2017年vs2021年vs2028年）：PNH、aHUS、その他 - 世界のソリリス医薬品市場規模・予測 - 世界のソリリス医薬品生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Alexion ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：血漿交換、血漿注入 ・アプリケーション別分析2017年-2028年：PNH、aHUS、その他 ・ソリリス医薬品の北米市場分析 - ソリリス医薬品の北米市場：タイプ別市場規模2017年-2028年 - ソリリス医薬品の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ソリリス医薬品のヨーロッパ市場分析 - ：ソリリス医薬品のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：ソリリス医薬品のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ソリリス医薬品のアジア太平洋市場分析 - ソリリス医薬品のアジア太平洋市場：タイプ別市場規模2017年-2028年 - ソリリス医薬品のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ソリリス医薬品の南米市場分析 - ソリリス医薬品の南米市場：タイプ別市場規模2017年-2028年 - ソリリス医薬品の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ソリリス医薬品の中東・アフリカ市場分析 - ソリリス医薬品の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - ソリリス医薬品の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Soliris Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Soliris Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. PNH accounting for % of the Soliris Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Plasma Exchange segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Soliris Drug include Alexion, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Soliris Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Plasma Exchange
Plasma Infusion
Market segment by Application can be divided into
PNH
aHUS
Other
The key market players for global Soliris Drug market are listed below:
Alexion
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Soliris Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Soliris Drug, with price, sales, revenue and global market share of Soliris Drug from 2019 to 2022.
Chapter 3, the Soliris Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Soliris Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Soliris Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Soliris Drug.
Chapter 13, 14, and 15, to describe Soliris Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Soliris Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Soliris Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Plasma Exchange
1.2.3 Plasma Infusion
1.3 Market Analysis by Application
1.3.1 Overview: Global Soliris Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 PNH
1.3.3 aHUS
1.3.4 Other
1.4 Global Soliris Drug Market Size & Forecast
1.4.1 Global Soliris Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Soliris Drug Sales in Volume (2017-2028)
1.4.3 Global Soliris Drug Price (2017-2028)
1.5 Global Soliris Drug Production Capacity Analysis
1.5.1 Global Soliris Drug Total Production Capacity (2017-2028)
1.5.2 Global Soliris Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Soliris Drug Market Drivers
1.6.2 Soliris Drug Market Restraints
1.6.3 Soliris Drug Trends Analysis
2 Manufacturers Profiles
2.1 Alexion
2.1.1 Alexion Details
2.1.2 Alexion Major Business
2.1.3 Alexion Soliris Drug Product and Services
2.1.4 Alexion Soliris Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Soliris Drug Breakdown Data by Manufacturer
3.1 Global Soliris Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Soliris Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Soliris Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Soliris Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Soliris Drug Manufacturer Market Share in 2021
3.5 Global Soliris Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Soliris Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Soliris Drug Market Size by Region
4.1.1 Global Soliris Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Soliris Drug Revenue by Region (2017-2028)
4.2 North America Soliris Drug Revenue (2017-2028)
4.3 Europe Soliris Drug Revenue (2017-2028)
4.4 Asia-Pacific Soliris Drug Revenue (2017-2028)
4.5 South America Soliris Drug Revenue (2017-2028)
4.6 Middle East and Africa Soliris Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Soliris Drug Sales in Volume by Type (2017-2028)
5.2 Global Soliris Drug Revenue by Type (2017-2028)
5.3 Global Soliris Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Soliris Drug Sales in Volume by Application (2017-2028)
6.2 Global Soliris Drug Revenue by Application (2017-2028)
6.3 Global Soliris Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Soliris Drug Sales by Type (2017-2028)
7.2 North America Soliris Drug Sales by Application (2017-2028)
7.3 North America Soliris Drug Market Size by Country
7.3.1 North America Soliris Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Soliris Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Soliris Drug Sales by Type (2017-2028)
8.2 Europe Soliris Drug Sales by Application (2017-2028)
8.3 Europe Soliris Drug Market Size by Country
8.3.1 Europe Soliris Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Soliris Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Soliris Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Soliris Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Soliris Drug Market Size by Region
9.3.1 Asia-Pacific Soliris Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Soliris Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Soliris Drug Sales by Type (2017-2028)
10.2 South America Soliris Drug Sales by Application (2017-2028)
10.3 South America Soliris Drug Market Size by Country
10.3.1 South America Soliris Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Soliris Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Soliris Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Soliris Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Soliris Drug Market Size by Country
11.3.1 Middle East & Africa Soliris Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Soliris Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Soliris Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Soliris Drug
12.3 Soliris Drug Production Process
12.4 Soliris Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Soliris Drug Typical Distributors
13.3 Soliris Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Soliris Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Soliris Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Alexion Basic Information, Manufacturing Base and Competitors
Table 4. Alexion Major Business
Table 5. Alexion Soliris Drug Product and Services
Table 6. Alexion Soliris Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Global Soliris Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 8. Global Soliris Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 9. Market Position of Manufacturers in Soliris Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 10. Global Soliris Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and Soliris Drug Production Site of Key Manufacturer
Table 12. Soliris Drug New Entrant and Capacity Expansion Plans
Table 13. Soliris Drug Mergers & Acquisitions in the Past Five Years
Table 14. Global Soliris Drug Sales by Region (2017-2022) & (K Units)
Table 15. Global Soliris Drug Sales by Region (2023-2028) & (K Units)
Table 16. Global Soliris Drug Revenue by Region (2017-2022) & (USD Million)
Table 17. Global Soliris Drug Revenue by Region (2023-2028) & (USD Million)
Table 18. Global Soliris Drug Sales by Type (2017-2022) & (K Units)
Table 19. Global Soliris Drug Sales by Type (2023-2028) & (K Units)
Table 20. Global Soliris Drug Revenue by Type (2017-2022) & (USD Million)
Table 21. Global Soliris Drug Revenue by Type (2023-2028) & (USD Million)
Table 22. Global Soliris Drug Price by Type (2017-2022) & (USD/Unit)
Table 23. Global Soliris Drug Price by Type (2023-2028) & (USD/Unit)
Table 24. Global Soliris Drug Sales by Application (2017-2022) & (K Units)
Table 25. Global Soliris Drug Sales by Application (2023-2028) & (K Units)
Table 26. Global Soliris Drug Revenue by Application (2017-2022) & (USD Million)
Table 27. Global Soliris Drug Revenue by Application (2023-2028) & (USD Million)
Table 28. Global Soliris Drug Price by Application (2017-2022) & (USD/Unit)
Table 29. Global Soliris Drug Price by Application (2023-2028) & (USD/Unit)
Table 30. North America Soliris Drug Sales by Country (2017-2022) & (K Units)
Table 31. North America Soliris Drug Sales by Country (2023-2028) & (K Units)
Table 32. North America Soliris Drug Revenue by Country (2017-2022) & (USD Million)
Table 33. North America Soliris Drug Revenue by Country (2023-2028) & (USD Million)
Table 34. North America Soliris Drug Sales by Type (2017-2022) & (K Units)
Table 35. North America Soliris Drug Sales by Type (2023-2028) & (K Units)
Table 36. North America Soliris Drug Sales by Application (2017-2022) & (K Units)
Table 37. North America Soliris Drug Sales by Application (2023-2028) & (K Units)
Table 38. Europe Soliris Drug Sales by Country (2017-2022) & (K Units)
Table 39. Europe Soliris Drug Sales by Country (2023-2028) & (K Units)
Table 40. Europe Soliris Drug Revenue by Country (2017-2022) & (USD Million)
Table 41. Europe Soliris Drug Revenue by Country (2023-2028) & (USD Million)
Table 42. Europe Soliris Drug Sales by Type (2017-2022) & (K Units)
Table 43. Europe Soliris Drug Sales by Type (2023-2028) & (K Units)
Table 44. Europe Soliris Drug Sales by Application (2017-2022) & (K Units)
Table 45. Europe Soliris Drug Sales by Application (2023-2028) & (K Units)
Table 46. Asia-Pacific Soliris Drug Sales by Region (2017-2022) & (K Units)
Table 47. Asia-Pacific Soliris Drug Sales by Region (2023-2028) & (K Units)
Table 48. Asia-Pacific Soliris Drug Revenue by Region (2017-2022) & (USD Million)
Table 49. Asia-Pacific Soliris Drug Revenue by Region (2023-2028) & (USD Million)
Table 50. Asia-Pacific Soliris Drug Sales by Type (2017-2022) & (K Units)
Table 51. Asia-Pacific Soliris Drug Sales by Type (2023-2028) & (K Units)
Table 52. Asia-Pacific Soliris Drug Sales by Application (2017-2022) & (K Units)
Table 53. Asia-Pacific Soliris Drug Sales by Application (2023-2028) & (K Units)
Table 54. South America Soliris Drug Sales by Country (2017-2022) & (K Units)
Table 55. South America Soliris Drug Sales by Country (2023-2028) & (K Units)
Table 56. South America Soliris Drug Revenue by Country (2017-2022) & (USD Million)
Table 57. South America Soliris Drug Revenue by Country (2023-2028) & (USD Million)
Table 58. South America Soliris Drug Sales by Type (2017-2022) & (K Units)
Table 59. South America Soliris Drug Sales by Type (2023-2028) & (K Units)
Table 60. South America Soliris Drug Sales by Application (2017-2022) & (K Units)
Table 61. South America Soliris Drug Sales by Application (2023-2028) & (K Units)
Table 62. Middle East & Africa Soliris Drug Sales by Region (2017-2022) & (K Units)
Table 63. Middle East & Africa Soliris Drug Sales by Region (2023-2028) & (K Units)
Table 64. Middle East & Africa Soliris Drug Revenue by Region (2017-2022) & (USD Million)
Table 65. Middle East & Africa Soliris Drug Revenue by Region (2023-2028) & (USD Million)
Table 66. Middle East & Africa Soliris Drug Sales by Type (2017-2022) & (K Units)
Table 67. Middle East & Africa Soliris Drug Sales by Type (2023-2028) & (K Units)
Table 68. Middle East & Africa Soliris Drug Sales by Application (2017-2022) & (K Units)
Table 69. Middle East & Africa Soliris Drug Sales by Application (2023-2028) & (K Units)
Table 70. Soliris Drug Raw Material
Table 71. Key Manufacturers of Soliris Drug Raw Materials
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Soliris Drug Typical Distributors
Table 75. Soliris Drug Typical Customers
List of Figures
Figure 1. Soliris Drug Picture
Figure 2. Global Soliris Drug Revenue Market Share by Type in 2021
Figure 3. Plasma Exchange
Figure 4. Plasma Infusion
Figure 5. Global Soliris Drug Revenue Market Share by Application in 2021
Figure 6. PNH
Figure 7. aHUS
Figure 8. Other
Figure 9. Global Soliris Drug Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Soliris Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Soliris Drug Sales (2017-2028) & (K Units)
Figure 12. Global Soliris Drug Price (2017-2028) & (USD/Unit)
Figure 13. Global Soliris Drug Production Capacity (2017-2028) & (K Units)
Figure 14. Global Soliris Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Soliris Drug Market Drivers
Figure 16. Soliris Drug Market Restraints
Figure 17. Soliris Drug Market Trends
Figure 18. Global Soliris Drug Sales Market Share by Manufacturer in 2021
Figure 19. Global Soliris Drug Revenue Market Share by Manufacturer in 2021
Figure 20. Soliris Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Soliris Drug Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Soliris Drug Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Soliris Drug Sales Market Share by Region (2017-2028)
Figure 24. Global Soliris Drug Revenue Market Share by Region (2017-2028)
Figure 25. North America Soliris Drug Revenue (2017-2028) & (USD Million)
Figure 26. Europe Soliris Drug Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Soliris Drug Revenue (2017-2028) & (USD Million)
Figure 28. South America Soliris Drug Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Soliris Drug Revenue (2017-2028) & (USD Million)
Figure 30. Global Soliris Drug Sales Market Share by Type (2017-2028)
Figure 31. Global Soliris Drug Revenue Market Share by Type (2017-2028)
Figure 32. Global Soliris Drug Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Soliris Drug Sales Market Share by Application (2017-2028)
Figure 34. Global Soliris Drug Revenue Market Share by Application (2017-2028)
Figure 35. Global Soliris Drug Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Soliris Drug Sales Market Share by Type (2017-2028)
Figure 37. North America Soliris Drug Sales Market Share by Application (2017-2028)
Figure 38. North America Soliris Drug Sales Market Share by Country (2017-2028)
Figure 39. North America Soliris Drug Revenue Market Share by Country (2017-2028)
Figure 40. United States Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Soliris Drug Sales Market Share by Type (2017-2028)
Figure 44. Europe Soliris Drug Sales Market Share by Application (2017-2028)
Figure 45. Europe Soliris Drug Sales Market Share by Country (2017-2028)
Figure 46. Europe Soliris Drug Revenue Market Share by Country (2017-2028)
Figure 47. Germany Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Soliris Drug Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Soliris Drug Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Soliris Drug Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Soliris Drug Revenue Market Share by Region (2017-2028)
Figure 56. China Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Soliris Drug Sales Market Share by Type (2017-2028)
Figure 63. South America Soliris Drug Sales Market Share by Application (2017-2028)
Figure 64. South America Soliris Drug Sales Market Share by Country (2017-2028)
Figure 65. South America Soliris Drug Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Soliris Drug Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Soliris Drug Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Soliris Drug Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Soliris Drug Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Soliris Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Soliris Drug in 2021
Figure 77. Manufacturing Process Analysis of Soliris Drug
Figure 78. Soliris Drug Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source